-
2 months ago | 
medicalnewstoday.com | Deep Shukla
Share on PinterestPrior research suggests that physical activity can slow down the development of Alzheimer’s disease and the accompanying abnormal accumulation of beta-amyloid and tau protein in the brain. A new study involving aged rats suggests that exercise may influence the interactions between brain cells in the hippocampus, a brain region involved in learning and memory.
-
2 months ago | 
medicalnewstoday.com | Deep Shukla
Share on PinterestAging and limited physical activity, as well as the use of novel weight loss drugs such as Wegovy and Zepbound, often lead to the simultaneous loss of muscle mass and bone density. Medications are currently available for bone loss, but approved treatments for muscle mass loss are lacking. A new study in mice shows that the antibody treatment bimagrumab can simultaneously prevent a decline in bone density along with muscle mass.
-
Dec 30, 2024 | 
resources.healthgrades.com | Deep Shukla
Research suggests that less than six hours of sleep is associated with an increased risk of cognitive impairment and high blood pressure. A new study now shows that shorter sleep duration could interact with high blood pressure to increase the risk of poor cognitive function and brain aging.
-
Nov 26, 2024 | 
medicalnewstoday.com | Deep Shukla
Share on PinterestThe development of glucagon-like peptide-1 (GLP-1) drugs, such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss, researchers and medical professionals have raised concerns about the accompanying loss of muscle tissue.
-
Nov 26, 2024 | 
resources.healthgrades.com | Deep Shukla
The development of glucagon-like peptide-1 (GLP-1) drugs, such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss, researchers and medical professionals have raised concerns about the accompanying loss of muscle tissue.
-
Oct 28, 2024 | 
resources.healthgrades.com | Deep Shukla
Vitamin D deficiency, especially in early life, is linked to an increased risk of autoimmune conditions, such as type 1 diabetes. Autoimmune diseases can be caused by a failure of T cells, a type of white blood cell, to distinguish unhealthy or infected cells from healthy ones. A new study conducted in mice shows that vitamin D deficiency led to the development of T cells that elicit an excessive immune response against healthy tissue.
-
Oct 28, 2024 | 
medicalnewstoday.com | Deep Shukla
Share on PinterestVitamin D deficiency, especially in early life, is linked to an increased risk of autoimmune conditions, such as type 1 diabetes. Autoimmune diseases can be caused by a failure of T cells, a type of white blood cell, to distinguish unhealthy or infected cells from healthy ones. A new study conducted in mice shows that vitamin D deficiency led to the development of T cells that elicit an excessive immune response against healthy tissue.
-
Oct 1, 2024 | 
healthgrades.com | Deep Shukla
Diseases that affect the retina, the light-sensitive layer at the back of the eye, are a significant cause of visual impairment and blindness. Gene therapy holds promise for treating some of these conditions, and current research advances may soon shift the therapeutic landscape for eye health. However, many obstacles remain in place, as this Special Feature discusses. Gene therapy uses genetic material, either DNA or RNA, to treat or prevent the progression of a disease.
-
Oct 1, 2024 | 
medicalnewstoday.com | Deep Shukla
Diseases that affect the retina, the light-sensitive layer at the back of the eye, are a significant cause of visual impairment and blindness. Gene therapy holds promise for treating some of these conditions, and current research advances may soon shift the therapeutic landscape for eye health. However, many obstacles remain in place, as this Special Feature discusses. Share on PinterestGene therapy uses genetic material, either DNA or RNA, to treat or prevent the progression of a disease.
-
Sep 11, 2024 | 
healthgrades.com | Deep Shukla
Diagnosis of Alzheimer’s disease has relied on cognitive symptoms until recently. While brain imaging scans and cerebrospinal fluid assays can be used for Alzheimer’s diagnosis, these methods are expensive, invasive, or not easily accessible. Technological advances have finally led to the development of ultra-sensitive blood-based biomarkers that could allow early and inexpensive diagnosis and follow-up.
